Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction

Abstract The aim of the present study is to systematically evaluate the impact of RDN on cardiac structure and function in patients with resistant hypertension (RH) or diastolic dysfunction. We retrieved Pubmed, Embase and Cocharane Library databases, from inception to April 1st, 2016. Studies repor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shiying Wang, Suxia Yang, Xinxin Zhao, Jun Shi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8abb375ab6dc49ceaffd07f6048cae98
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8abb375ab6dc49ceaffd07f6048cae98
record_format dspace
spelling oai:doaj.org-article:8abb375ab6dc49ceaffd07f6048cae982021-12-02T15:07:47ZEffects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction10.1038/s41598-017-18671-62045-2322https://doaj.org/article/8abb375ab6dc49ceaffd07f6048cae982018-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-18671-6https://doaj.org/toc/2045-2322Abstract The aim of the present study is to systematically evaluate the impact of RDN on cardiac structure and function in patients with resistant hypertension (RH) or diastolic dysfunction. We retrieved Pubmed, Embase and Cocharane Library databases, from inception to April 1st, 2016. Studies reporting left ventricular mass (LVMI) or left ventricular (LV) diastolic function (reflected by the ratio of mitral inflow velocity to annular relaxation velocity [E/e’]) responses to RDN were included. Two randomized controlled trials (RCTs), 3 controlled studies and 11 uncontrolled studies were finally identified. In observational studies, there was a reduction in LVMI, E/e’ and N-terminal pro B-type natriuretic peptide (BNP) at 6 months, compared with pre-RDN values. LV ejection fraction (LVEF) elevated at 6 months following RDN. In RCTs, however, no significant change in LVMI, E/e’, BNP, left atrial volume index or LVEF was observed at 12 months, compared with pharmaceutical therapy. In summary, both LV hypertrophy and cardiac function improved at 6 months after RDN. Nonetheless, current evidence failed to show that RDN was superior to intensive (optimal) drug therapy in improving cardiac remodeling and function.Shiying WangSuxia YangXinxin ZhaoJun ShiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shiying Wang
Suxia Yang
Xinxin Zhao
Jun Shi
Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction
description Abstract The aim of the present study is to systematically evaluate the impact of RDN on cardiac structure and function in patients with resistant hypertension (RH) or diastolic dysfunction. We retrieved Pubmed, Embase and Cocharane Library databases, from inception to April 1st, 2016. Studies reporting left ventricular mass (LVMI) or left ventricular (LV) diastolic function (reflected by the ratio of mitral inflow velocity to annular relaxation velocity [E/e’]) responses to RDN were included. Two randomized controlled trials (RCTs), 3 controlled studies and 11 uncontrolled studies were finally identified. In observational studies, there was a reduction in LVMI, E/e’ and N-terminal pro B-type natriuretic peptide (BNP) at 6 months, compared with pre-RDN values. LV ejection fraction (LVEF) elevated at 6 months following RDN. In RCTs, however, no significant change in LVMI, E/e’, BNP, left atrial volume index or LVEF was observed at 12 months, compared with pharmaceutical therapy. In summary, both LV hypertrophy and cardiac function improved at 6 months after RDN. Nonetheless, current evidence failed to show that RDN was superior to intensive (optimal) drug therapy in improving cardiac remodeling and function.
format article
author Shiying Wang
Suxia Yang
Xinxin Zhao
Jun Shi
author_facet Shiying Wang
Suxia Yang
Xinxin Zhao
Jun Shi
author_sort Shiying Wang
title Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction
title_short Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction
title_full Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction
title_fullStr Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction
title_full_unstemmed Effects of Renal Denervation on Cardiac Structural and Functional Abnormalities in Patients with Resistant Hypertension or Diastolic Dysfunction
title_sort effects of renal denervation on cardiac structural and functional abnormalities in patients with resistant hypertension or diastolic dysfunction
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/8abb375ab6dc49ceaffd07f6048cae98
work_keys_str_mv AT shiyingwang effectsofrenaldenervationoncardiacstructuralandfunctionalabnormalitiesinpatientswithresistanthypertensionordiastolicdysfunction
AT suxiayang effectsofrenaldenervationoncardiacstructuralandfunctionalabnormalitiesinpatientswithresistanthypertensionordiastolicdysfunction
AT xinxinzhao effectsofrenaldenervationoncardiacstructuralandfunctionalabnormalitiesinpatientswithresistanthypertensionordiastolicdysfunction
AT junshi effectsofrenaldenervationoncardiacstructuralandfunctionalabnormalitiesinpatientswithresistanthypertensionordiastolicdysfunction
_version_ 1718388401452875776